Literature DB >> 8346100

Trichothiodystrophy and associated anomalies: a variant of SIBIDS or new symptom complex?

J H Hersh1, L R Klein, M R Joyce, M K Hordinsky, M Y Tsai, A Paller, R Hyzer, R H Zax.   

Abstract

Trichothiodystrophy is characterized by sparse, short, sulfur-deficient hair. Numerous symptom complexes have been described in which the hair abnormality represents a constant feature. We report a boy with trichothiodystrophy, ichthyotic skin changes, onychodystrophy, chronic neutropenia, osteosclerosis, hypothyroidism, nystagmus, growth and mental retardation, and microcephaly, who developed a progressive encephalopathy with ataxia and optic atrophy at 2.5 years of age. In addition to a deficient cystine level identified on a hair sample, a disturbance in the composition of other amino acids was present. Although features were reminiscent of osteosclerosis, ichthyosis, brittle hair due to trichothiodystrophy, impaired intelligence, decreased fertility, and short stature (SIBIDS) and could represent a variant of this disorder, findings in our patient may reflect a new trichothiodystrophy symptom complex that carries a poor prognosis for survival beyond childhood.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8346100     DOI: 10.1111/j.1525-1470.1993.tb00034.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  3 in total

1.  Cerebellar and cerebral atrophy in trichothiodystrophy.

Authors:  Hye-Kyung Yoon; Michael A Sargent; Julie S Prendiville; Kenneth J Poskitt
Journal:  Pediatr Radiol       Date:  2005-05-24

Review 2.  Trichothiodystrophy: a systematic review of 112 published cases characterises a wide spectrum of clinical manifestations.

Authors:  S Faghri; D Tamura; K H Kraemer; J J Digiovanna
Journal:  J Med Genet       Date:  2008-06-25       Impact factor: 6.318

Review 3.  Male fertility and skin diseases.

Authors:  M Badawy Abdel-Naser; Christos C Zouboulis
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 9.306

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.